2015 Fiscal Year Final Research Report
Generation of anti-fibrotic therapy to combat progression of CKD via CCN2 blockade
Project/Area Number |
25461228
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Kidney internal medicine
|
Research Institution | Saitama Medical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
INOUE Tsutomu 埼玉医科大学, 医学部, 准教授 (30406475)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Keywords | CCN2 / 腎線維化 / 遺伝子改変動物 / CKD / 尿細管上皮細胞 / 線維芽細胞 |
Outline of Final Research Achievements |
CCN2 consists of four different functional modules, and the most profibrogenic module remains to be clarified. We found a module IV-defective CCN2 did not induce fibronectin synthesis in fibroblasts. Then, we generated Exon 5-deleted CCN2 gene knockin mice, found less kidney fibrosis in those mice with unilateral ureter obstruction and subtotally nephrectomy models. Decoy peptides corresponding to partial amino acid sequences of module IV significantly attenuated renal fibrogenesis. This suggests that CCN2 promotes renal fibrogenesis via its module IV, probably through Integrins-Integrin linked kinase-Akt-GSK3β pathway, which seems to be an appropriate, anti-fibrotic therapeutic target.
|
Free Research Field |
腎臓内科学
|